BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Deals

  SYGNIS Pharma AG and GENETRIX Announce Proposed Combination of Businesses of SYGNIS and GENETRIX’ Subsidiary X-Pol

  July 18, 2012

   · 

  5 min read
• Pharm Country

  NMS Labs Release: Clandestine Chemists Diversify to Stay Ahead of Latest Round of Drug Scheduling

  July 18, 2012

   · 

  1 min read
• Drug Development

  23andMe, Inc. and MediGuard.org Conducting Rheumatoid Arthritis Study Sponsored by Janssen Healthcare Innovation, a Unit of Janssen Research & Development, LLC

  July 18, 2012

   · 

  1 min read
• Biotech Beach

  TrovaGene, Inc. Announces Issuance of U.S. Patent for NPM Mutants to Diagnose and Monitor Acute Myeloid Leukemia

  July 18, 2012

   · 

  4 min read
• Biotech Beach

  Masimo Corporation Release: Pulse Oximetry Screening Hailed as the “New Milestone” to Combat Critical Congenital Heart Disease - Signal Extraction Technology Leading the Way in Large, Independent Clinical Studies

  July 18, 2012

   · 

  5 min read
• Pharm Country

  US Consul General Applauds Almac Group’s Economic Contribution to the US Pharmaceuticals Market

  July 18, 2012

   · 

  2 min read
• Biotech Beach

  International Stem Cell Corporation’s Co-Chairman and CEO Andrey Semechkin PhD Publishes Letter to Shareholders

  July 18, 2012

   · 

  3 min read
• Biotech Bay

  SpineGuard’s PediGuard® Device Reduces by 30% Spine Surgeons’ Radiation Exposure From Fluoroscopy While Maintaining a 97.5% Accurate Pedicle Screw Placement During Lumbar Spine Fusion

  July 18, 2012

   · 

  4 min read
• Business

  Innospec Schedules Second Quarter 2012 Earnings Release and Conference Call

  July 18, 2012

   · 

  1 min read
• Policy

  Hemispherx Biopharma Filing a New Drug Application in Argentina for Ampligen® to Treat Chronic Fatigue Syndrome

  July 18, 2012

   · 

  1 min read